Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Carcinoma, Renal Cell × 1 year × Clear all

Status

Recruiting 172 Active not recruiting 114 Completed 62 Not yet recruiting 34 Terminated 31 Withdrawn 7 Suspended 6 Enrolling by invitation 4 Available 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Recurrence 4 Prostatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, Large B-Cell, Diffuse 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neuroblastoma 3 Leukemia, Myeloid, Acute 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Primary Myelofibrosis 2 Osteosarcoma 2 Non-Muscle Invasive Bladder Neoplasms 2 Neuroectodermal Tumors, Primitive 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma 2 Insulinoma 2 Immunologic Deficiency Syndromes 2 Hypoglycemia 2 Hyperinsulinism 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Glioblastoma 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06090331 2025-07-08

89Zr-DFO-girentuximab Expanded Access Program (EAP)

Telix Pharmaceuticals (Innovations) Pty Limited

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡